Contineum Therapeutics, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Contineum Therapeutics, Inc. (CTNM) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2025-10-30
- Contineum Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2024-12-31 was $0.00.
- Contineum Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2023-12-31 was $0.00.
- Contineum Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2024 was $16.00K.
- Contineum Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $16.00K 10-K · filed 2025-03-06 | |
| 2024-09-30 | $16.00K 10-Q · filed 2025-10-30 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |